viagra timetable, page-2

So that's the USA patent extension kippax, what about protection in other geographies or is that covered as well? US Viagra sales are only about half of Pfizer's market.

So apparently Mylan also has a generic Viagra ready to launch in 2017 but I havent heard of any kind of payment to Pfizer on that one. It will be interestng to see how that one moves.

Add to this that the Eli Lilly patent on Cialis also expires in 2017 as well and I havent seen any word on an extension.

A new spray viagra with quicker onset of action could potentially take sales off the generics for that as well and potentially grow the market for Viagra again.

Interesting you'd think Pfizer would be right on this, they lost huge amounts of revenue when Lipitor went open to generics, cutting their returns to 1/5th of its previous size. They would be accutely aware. I cant believe they think all generic suppliers will come knocking for a deal.

The downside of a spray over a pill is the potential taste. This may be what is causing some concern. Upside is obviously the lack of impact on the gut and the better onset of action.

But the clock is ticking, Pfizer would have to start softening the market on the need for a little blue spray instead of a little blue pill well before they'd switch across. Also, if I was Teva, a deal would mean they are covered license wise and also able to market differentiate via a spray version.